forecast

Non-Invasive Glucose Monitoring Is the Technology Risk

The second major risk is technological: a non-invasive glucose monitor that avoids penetrating the skin could displace current CGMs, and prior attempts such as Novartis's contact lens and GlucoWatch failed on accuracy and skin irritation.

forecastpending

Speaker

Aneal

Evidence Quote

“Dexcom and Abbott and the MiniMed device all go underneath the skin. One thing that I'm particularly focused on is non-invasive glucose monitoring.”

Source

Dexcom: Digitizing Diabetes Management— Business Breakdowns
Created: 11/20/2026, 5:18:27 AM

Your notes

Loading notes...